BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 23498975)

  • 1. Pathogenic VCP mutations induce mitochondrial uncoupling and reduced ATP levels.
    Bartolome F; Wu HC; Burchell VS; Preza E; Wray S; Mahoney CJ; Fox NC; Calvo A; Canosa A; Moglia C; Mandrioli J; Chiò A; Orrell RW; Houlden H; Hardy J; Abramov AY; Plun-Favreau H
    Neuron; 2013 Apr; 78(1):57-64. PubMed ID: 23498975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic variability in three families with valosin-containing protein mutation.
    Spina S; Van Laar AD; Murrell JR; Hamilton RL; Kofler JK; Epperson F; Farlow MR; Lopez OL; Quinlan J; DeKosky ST; Ghetti B
    Eur J Neurol; 2013 Feb; 20(2):251-8. PubMed ID: 22900631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The heterozygous R155C VCP mutation: Toxic in humans! Harmless in mice?
    Clemen CS; Winter L; Strucksberg KH; Berwanger C; Türk M; Kornblum C; Florin A; Aguilar-Pimentel JA; Amarie OV; Becker L; Garrett L; Hans W; Moreth K; Neff F; Pingen L; Rathkolb B; Rácz I; Rozman J; Treise I; Fuchs H; Gailus-Durner V; de Angelis MH; Vorgerd M; Eichinger L; Schröder R
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2770-2777. PubMed ID: 30100055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The homozygote VCP(R¹⁵⁵H/R¹⁵⁵H) mouse model exhibits accelerated human VCP-associated disease pathology.
    Nalbandian A; Llewellyn KJ; Kitazawa M; Yin HZ; Badadani M; Khanlou N; Edwards R; Nguyen C; Mukherjee J; Mozaffar T; Watts G; Weiss J; Kimonis VE
    PLoS One; 2012; 7(9):e46308. PubMed ID: 23029473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenic VCP/TER94 alleles are dominant actives and contribute to neurodegeneration by altering cellular ATP level in a Drosophila IBMPFD model.
    Chang YC; Hung WT; Chang YC; Chang HC; Wu CL; Chiang AS; Jackson GR; Sang TK
    PLoS Genet; 2011 Feb; 7(2):e1001288. PubMed ID: 21304887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different dynamic movements of wild-type and pathogenic VCPs and their cofactors to damaged mitochondria in a Parkin-mediated mitochondrial quality control system.
    Kimura Y; Fukushi J; Hori S; Matsuda N; Okatsu K; Kakiyama Y; Kawawaki J; Kakizuka A; Tanaka K
    Genes Cells; 2013 Dec; 18(12):1131-43. PubMed ID: 24215292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Motor neuron involvement in multisystem proteinopathy: implications for ALS.
    Benatar M; Wuu J; Fernandez C; Weihl CC; Katzen H; Steele J; Oskarsson B; Taylor JP
    Neurology; 2013 May; 80(20):1874-80. PubMed ID: 23635965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The multiple faces of valosin-containing protein-associated diseases: inclusion body myopathy with Paget's disease of bone, frontotemporal dementia, and amyotrophic lateral sclerosis.
    Nalbandian A; Donkervoort S; Dec E; Badadani M; Katheria V; Rana P; Nguyen C; Mukherjee J; Caiozzo V; Martin B; Watts GD; Vesa J; Smith C; Kimonis VE
    J Mol Neurosci; 2011 Nov; 45(3):522-31. PubMed ID: 21892620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel valosin containing protein mutation in a Swiss family with hereditary inclusion body myopathy and dementia.
    Peyer AK; Kinter J; Hench J; Frank S; Fuhr P; Thomann S; Fischmann A; Kneifel S; Camaño P; López de Munain A; Sinnreich M; Renaud S
    Neuromuscul Disord; 2013 Feb; 23(2):149-54. PubMed ID: 23140793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel VCP mutation as the cause of atypical IBMPFD in a Chinese family.
    Gu JM; Ke YH; Yue H; Liu YJ; Zhang Z; Zhang H; Hu WW; Wang C; He JW; Hu YQ; Li M; Fu WZ; Zhang ZL
    Bone; 2013 Jan; 52(1):9-16. PubMed ID: 23000505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Myoblast C2C12 Transfected with Mutant Valosin-Containing Protein Exhibits Delayed Stress Granule Resolution on Oxidative Stress.
    Rodriguez-Ortiz CJ; Flores JC; Valenzuela JA; Rodriguez GJ; Zumkehr J; Tran DN; Kimonis VE; Kitazawa M
    Am J Pathol; 2016 Jun; 186(6):1623-34. PubMed ID: 27106764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valosin-containing protein (VCP) is a novel IQ motif-containing GTPase activating protein 1 (IQGAP1)-interacting protein.
    Itoh N; Nagai T; Watanabe T; Taki K; Nabeshima T; Kaibuchi K; Yamada K
    Biochem Biophys Res Commun; 2017 Dec; 493(4):1384-1389. PubMed ID: 28970065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuronal-specific overexpression of a mutant valosin-containing protein associated with IBMPFD promotes aberrant ubiquitin and TDP-43 accumulation and cognitive dysfunction in transgenic mice.
    Rodriguez-Ortiz CJ; Hoshino H; Cheng D; Liu-Yescevitz L; Blurton-Jones M; Wolozin B; LaFerla FM; Kitazawa M
    Am J Pathol; 2013 Aug; 183(2):504-15. PubMed ID: 23747512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleocytoplasmic shuttling of valosin-containing protein (VCP/p97) regulated by its N domain and C-terminal region.
    Song C; Wang Q; Song C; Lockett SJ; Colburn NH; Li CC; Wang JM; Rogers TJ
    Biochim Biophys Acta; 2015 Jan; 1853(1):222-32. PubMed ID: 25447673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A progressive translational mouse model of human valosin-containing protein disease: the VCP(R155H/+) mouse.
    Nalbandian A; Llewellyn KJ; Badadani M; Yin HZ; Nguyen C; Katheria V; Watts G; Mukherjee J; Vesa J; Caiozzo V; Mozaffar T; Weiss JH; Kimonis VE
    Muscle Nerve; 2013 Feb; 47(2):260-70. PubMed ID: 23169451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A patient with familial amyotrophic lateral sclerosis associated with a new valosin-containing protein (VCP) gene mutation].
    Segawa M; Hoshi A; Naruse H; Kuroda M; Bujo H; Ugawa Y
    Rinsho Shinkeigaku; 2015; 55(12):914-20. PubMed ID: 26511028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inclusion body myopathy with Paget's disease of bone and frontotemporal dementia].
    Hayashi Y
    Rinsho Shinkeigaku; 2013; 53(11):947-50. PubMed ID: 24291843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valosin-containing protein (VCP) is required for autophagy and is disrupted in VCP disease.
    Ju JS; Fuentealba RA; Miller SE; Jackson E; Piwnica-Worms D; Baloh RH; Weihl CC
    J Cell Biol; 2009 Dec; 187(6):875-88. PubMed ID: 20008565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VCP/p97 controls signals of the ERK1/2 pathway transmitted via the Shoc2 scaffolding complex: novel insights into IBMPFD pathology.
    Jang H; Jang ER; Wilson PG; Anderson D; Galperin E
    Mol Biol Cell; 2019 Jul; 30(14):1655-1663. PubMed ID: 31091164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transgenic mice expressing mutant forms VCP/p97 recapitulate the full spectrum of IBMPFD including degeneration in muscle, brain and bone.
    Custer SK; Neumann M; Lu H; Wright AC; Taylor JP
    Hum Mol Genet; 2010 May; 19(9):1741-55. PubMed ID: 20147319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.